Chemours Co Stock Today

CC Stock  USD 28.88  1.51  5.52%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 26

 
100  
 
Zero
Below Average
Chemours is trading at 28.88 as of the 28th of March 2024, a 5.52 percent up since the beginning of the trading day. The stock's open price was 27.37. Chemours has about a 26 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Chemours Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Materials
IPO Date
1st of July 2015
Category
Basic Materials
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. The company has 148.44 M outstanding shares of which 4.71 M shares are currently sold short in the market by investors with about 2.01 days to cover all shorted shares. More on Chemours Co

Moving against Chemours Stock

  0.66DNMR Danimer Scientific Earnings Call TodayPairCorr
  0.6ASH Ashland Global Holdings Financial Report 7th of May 2024 PairCorr
  0.55NTIC Northern Technologies Report 11th of April 2024 PairCorr
  0.51WTTR Select Energy Services Financial Report 7th of May 2024 PairCorr

Chemours Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Chemours' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Chemours or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOMark Vergnano
Thematic Ideas
Showing 3 out of 6 themes
Old NameCredit Industriel et Commercial SA
Business ConcentrationDiversified Chemicals, Specialty Chemicals, Basic Materials, NYSE Composite, SP Midcap 400, Chemicals Makers, Synthetics, Plastics, Trump Equities, Chemicals, SRI Sustainable Growth, Materials, Chemicals, Specialty Chemicals, Basic Materials (View all Sectors)
Average Analyst Recommendation
Analysts covering Chemours report their recommendations after researching Chemours' financial statements, talking to executives and customers, or listening in on Chemours' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Chemours. The Chemours consensus assessment is calculated by taking the average forecast from all of the analysts covering Chemours.
Financial Strength
Based on the key indicators related to Chemours' liquidity, profitability, solvency, and operating efficiency, Chemours Co may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Chemours is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.051.02
Fairly Up
Slightly volatile
Gross Profit Margin0.260.27
Sufficiently Down
Slightly volatile
Net Debt2.3 B2.4 B
Sufficiently Down
Slightly volatile
Total Current Liabilities1.7 B2.2 B
Significantly Down
Slightly volatile
Non Current Liabilities TotalB5.3 B
Way Down
Slightly volatile
Total Assets7.3 B8.8 B
Fairly Down
Slightly volatile
Total Current Assets2.9 B3.7 B
Significantly Down
Slightly volatile
Total Cash From Operating Activities651.7 M678.6 M
Sufficiently Down
Slightly volatile
Chemours' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Chemours' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Chemours' bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Chemours' outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Chemours' financial leverage. It provides some insight into what part of Chemours' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Chemours' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Chemours deploys its capital and how much of that capital is borrowed.
Liquidity
Chemours cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company reports 3.81 B of total liabilities with total debt to equity ratio (D/E) of 2.94, which may imply that the company relies heavily on debt financing. Chemours has a current ratio of 1.78, which is generally considered normal. Debt can assist Chemours until it has trouble settling it off, either with new capital or with free cash flow. So, Chemours' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Chemours sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Chemours to invest in growth at high rates of return. When we think about Chemours' use of debt, we should always consider it together with cash and equity.

Stock Based Compensation

32.6 Million
Chemours Co (CC) is traded on New York Stock Exchange in USA. It is located in 1007 Market Street, Wilmington, DE, United States, 19801 and employs 6,600 people. Chemours is listed under Diversified Chemicals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a market capitalization of 4.25 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chemours's market, we take the total number of its shares issued and multiply it by Chemours's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Chemours is active under Chemicals sector as part of Materials industry. The entity has 148.44 M outstanding shares of which 4.71 M shares are currently sold short in the market by investors with about 2.01 days to cover all shorted shares. Chemours Co reports about 1.1 B in cash with 754 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.73.
Check Chemours Probability Of Bankruptcy
Ownership Allocation
Chemours retains a total of 148.44 Million outstanding shares. The majority of Chemours Co outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemours to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemours. Please pay attention to any change in the institutional holdings of Chemours Co as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Chemours Ownership Details

Chemours Stock Price Odds Analysis

What are Chemours' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Chemours jumping above the current price in 90 days from now is about 47.08%. The Chemours Co probability density function shows the probability of Chemours stock to fall within a particular range of prices over 90 days. Allowing for the 90-day total investment horizon the stock has a beta coefficient of 1.8311 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Chemours will likely underperform. Additionally, chemours Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 28.88HorizonTargetOdds Above 28.88
52.77%90 days
 28.88 
47.08%
Based on a normal probability distribution, the odds of Chemours to move above the current price in 90 days from now is about 47.08 (This Chemours Co probability density function shows the probability of Chemours Stock to fall within a particular range of prices over 90 days) .

Chemours Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Chemours that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chemours' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chemours' value.
InstituionRecorded OnShares
Geode Capital Management, Llc2023-12-31
2.3 M
American Century Companies Inc2023-12-31
1.4 M
Vaughan Nelson Scarbrgh & Mccullough Lp2023-12-31
1.4 M
Goldman Sachs Group Inc2023-12-31
1.3 M
Norges Bank2023-12-31
1.2 M
Charles Schwab Investment Management Inc2023-12-31
1.1 M
Northern Trust Corp2023-12-31
1.1 M
Legal & General Group Plc2023-12-31
1.1 M
Morgan Stanley - Brokerage Accounts2023-12-31
M
Blackrock Inc2023-12-31
16.5 M
Fmr Inc2023-12-31
16.4 M
View Chemours Diagnostics

Chemours Historical Income Statement

Chemours Co Income Statement is one of the three primary financial statements used for reporting Chemours's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Chemours revenue and expense. Chemours Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Chemours' Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 131.1 M, whereas Depreciation And Amortization is forecasted to decline to about 311.9 M. View More Fundamentals

Chemours Stock Against Markets

Picking the right benchmark for Chemours stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Chemours stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Chemours is critical whether you are bullish or bearish towards Chemours Co at a given time. Please also check how Chemours' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chemours without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Commodity Channel Now

   

Commodity Channel

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Chemours Corporate Directors

Chemours corporate directors refer to members of a Chemours board of directors. The board of directors generally takes responsibility for the Chemours' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Chemours' board members must vote for the resolution. The Chemours board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Curtis AnastasioIndependent DirectorProfile
Stephen NewlinIndependent DirectorProfile
Curtis CrawfordIndependent DirectorProfile
Mary CranstonIndependent DirectorProfile

How to buy Chemours Stock?

Before investing in Chemours, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Chemours. To buy Chemours stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Chemours. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Chemours stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Chemours Co stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Chemours Co stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Chemours Co, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Chemours Stock please use our How to Invest in Chemours guide.

Already Invested in Chemours Co?

The danger of trading Chemours Co is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Chemours is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Chemours. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Chemours is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Chemours offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chemours' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chemours Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chemours Co Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Chemours Stock analysis

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.91)
Dividend Share
1
Earnings Share
(2.00)
Revenue Per Share
40.243
Quarterly Revenue Growth
(0.16)
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.